Pictet Asset Management (Switzerland)’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $12.9M | Sell |
634,045
-649,798
| -51% | -$13.2M | 0.02% | 569 |
|
|
2023
Q1 | $23.4M | Buy |
1,283,843
+19,860
| +2% | +$362K | 0.03% | 427 |
|
|
2022
Q4 | $26.1M | Sell |
1,263,983
-225,460
| -15% | -$4.66M | 0.04% | 388 |
|
|
2022
Q3 | $39M | Sell |
1,489,443
-423,108
| -22% | -$11.1M | 0.06% | 311 |
|
|
2022
Q2 | $48.5M | Buy |
1,912,551
+357,539
| +23% | +$9.06M | 0.07% | 281 |
|
|
2022
Q1 | $49.1M | Sell |
1,555,012
-93,978
| -6% | -$2.97M | 0.06% | 312 |
|
|
2021
Q4 | $66.7M | Buy |
1,648,990
+147,762
| +10% | +$5.98M | 0.07% | 296 |
|
|
2021
Q3 | $52.3M | Buy |
+1,501,228
| New | +$52.3M | 0.06% | 329 |
|